Plasma copeptin levels exhibited higher clinical applicability in prediction of HF in patients with reduced left ventricular ejection fraction (38) or hyponatremia symptoms (39) and in prediction of all-cause death and readmission in HF patients (40). The gene discussed is AVP; the disease is hydrops fetalis.